What's Actually in a Ketamine Troche?
When you place a ketamine troche under your tongue, you're introducing a carefully formulated combination of pharmaceutical ingredients into your body. The therapeutic effect comes from the active ingredient — ketamine hydrochloride — but the inactive ingredients (excipients) play an equally important role in how the troche dissolves, how comfortable it is to use, how stable it remains on the shelf, and how efficiently the drug is absorbed. Understanding what's in your troche is part of informed, engaged patient care.
The Active Ingredient: Ketamine Hydrochloride
Chemical Identity
Ketamine HCl (chemical name: 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one hydrochloride) is the active pharmaceutical ingredient in all compounded ketamine troches. It is a water-soluble crystalline powder — white to off-white in appearance — that is incorporated into the troche base during compounding.
The "HCl" designation indicates that the ketamine molecule has been converted to its hydrochloride salt form, which is:
- More stable than the free base
- More water-soluble, facilitating dissolution in saliva
- Commercially available as a pharmaceutical-grade API from FDA-registered suppliers
Racemic vs. Enantiomers
Standard compounded ketamine is racemic — a 50/50 mixture of R-ketamine and S-ketamine enantiomers. These two molecular mirror images have different pharmacological properties. S-ketamine (esketamine) is the basis for FDA-approved Spravato nasal spray and is approximately twice as potent at NMDA receptors as R-ketamine. R-ketamine may contribute additional antidepressant effects through different mechanisms.
Some prescribers and pharmacies work with enantiopure formulations (pure S-ketamine or pure R-ketamine troches), though this is less common and typically requires prescriber-specific reasoning and a pharmacy capable of sourcing enantiopure API.
Dosage Range in Troches
Compounded ketamine troches are available across a wide dosage range:
- Low dose (50–100 mg): Often used for chronic pain management or as a starting point for highly sensitive patients
- Moderate dose (100–200 mg): The most common starting range for mental health indications
- Higher dose (200–400 mg): Used for patients who have titrated upward based on tolerability and response
The labeled dose on your prescription refers to the total milligrams of ketamine HCl per troche. At approximately 20 to 30 percent bioavailability — a figure explained in our article on troche absorption — a 200 mg troche delivers roughly 40 to 60 mg of ketamine to systemic circulation.
The Troche Base: PEG and Alternatives
The troche base is the material that gives the lozenge its physical form — holding the active ingredient in place, controlling dissolution rate, and determining the troche's physical characteristics.
Polyethylene Glycol (PEG) Base
PEG-based troche bases are the standard in most compounding pharmacies. PEG is a synthetic polymer available in various molecular weights; the most commonly used grades for troches are:
- PEG 1000: Lower molecular weight, melts at a lower temperature (around 37–40°C), produces a softer troche that dissolves relatively quickly
- PEG 3350: Higher molecular weight, melts at a higher temperature (around 50–55°C), produces a firmer troche with slower dissolution
- PEG blends: Most pharmacies use a combination of PEG 1000 and PEG 3350 in specific ratios to achieve the desired hardness and dissolution profile
PEG bases are:
- Non-irritating to oral mucosa at troche concentrations
- Inert (do not react with ketamine HCl)
- Hygroscopic (absorb moisture from air, which is why storage conditions matter)
- Generally well-tolerated, though some patients with PEG sensitivities should discuss alternatives with their pharmacy
Alternative Bases
For patients who cannot tolerate PEG, some pharmacies offer:
- Oleaginous bases: Fat-based (similar to suppository bases), which dissolve differently and may alter the dissolution and absorption profile
- Acacia-based bases: Natural gum-based, typically producing a firmer lozenge
- Sugar-based hard candy bases: Less common for pharmaceutical troches; may be used for taste improvement but typically produce slower drug release
Flavoring Agents
Ketamine HCl has a pronounced bitter, chemical taste. Flavoring agents are added to improve palatability and patient adherence. Pharmaceutical-grade flavoring concentrates used in troches are different from food-grade flavorings — they are formulated for compatibility with troche bases and controlled dissolution. For more on what your troche will actually taste like, see our guide on troche taste and form.
Common pharmaceutical flavoring options include:
- Spearmint or peppermint: Most widely used; provides the strongest masking of bitterness
- Grape: Popular pediatric-style flavor; effective for many patients
- Cherry: Common; may combine to produce an unusual taste profile with strong bitterness
- Watermelon or bubblegum: Less common; popular with some patient populations
- Vanilla or butterscotch: Neutral, non-fruit options
Flavor intensity is adjustable. Patients who find their current flavor insufficient or overwhelming can request modification from their pharmacy.
Sweeteners
Pharmaceutical sweeteners help mask the bitterness and improve overall palatability:
- Sucralose: Most commonly used; very sweet, heat-stable, does not ferment, suitable for diabetic patients
- Stevia: Natural sweetener option; some patients prefer it for philosophical reasons; slightly different taste profile
- Sorbitol: Sugar alcohol used in some formulations; can cause GI discomfort in large amounts but the quantities in troches are negligible
Preservatives
Not all compounded troches contain preservatives. The choice depends on pharmacy policy, patient preference, and the intended shelf life:
- Methylparaben / Propylparaben: Broad-spectrum antimicrobial preservatives used to prevent microbial growth over the troche's shelf life. Effective but controversial due to potential endocrine disruption at high chronic exposures (not relevant at troche dosing levels, but some patients prefer to avoid them).
- Benzalkonium chloride: Quaternary ammonium preservative; sometimes used in low concentrations.
- Preservative-free formulations: Many pharmacies offer these for patients with sensitivities. Preservative-free troches may have shorter beyond-use dates and may require more stringent storage conditions.
If preservatives are a concern for you, ask your compounding pharmacy explicitly whether their formulation is preservative-free. Our compounding pharmacy guide covers what to ask when evaluating a pharmacy.
Colorants
Colorants are sometimes added to troches:
- FD&C certified dyes: FDA-approved food and drug colorants (e.g., FD&C Red No. 40, FD&C Blue No. 1) used at cosmetic concentrations
- Natural colorants: Beetroot powder, turmeric, and spirulina extracts are occasionally used by pharmacies preferring natural ingredients
Colorants serve a practical purpose when multiple dose strengths are dispensed: color-coding reduces confusion and dosing errors.
Checking Your Troche's Ingredient List
Your compounding pharmacy should be able to provide a full ingredient list for your specific formulation on request. When reviewing this list:
- Confirm ketamine HCl is listed as the active ingredient with the correct mg amount matching your prescription.
- Note whether preservatives are included if this matters to you.
- Verify that the listed base, flavoring, and sweeteners do not include anything you have documented allergies or sensitivities to.
- Ask about PEG content if you have known PEG sensitivity (rare but documented).
Key Takeaways
- The active ingredient in all ketamine troches is ketamine HCl, a water-soluble salt of the ketamine molecule.
- Standard troches use racemic ketamine (50/50 R- and S-ketamine); enantiopure formulations are less common.
- PEG bases (typically a blend of PEG 1000 and PEG 3350) are the most commonly used troche bases.
- Excipients include flavoring agents, sweeteners, and optional preservatives.
- Patients can request ingredient lists from their pharmacy and ask for modifications based on sensitivities.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
- MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
- NIMH: Depression — National Institute of Mental Health overview of depressive disorders, treatment-resistant forms, and emerging therapies
- WHO: Depression Fact Sheet — World Health Organization global data on depression prevalence, burden, and treatment approaches
Share